Financial Times & Deloitte Global Pharmaceutical & Biotechnology Conference
This event brings together industry executives, thought leaders, and investors who wish to keep abreast of the emerging trends reshaping the global healthcare and life sciences industry.
Real World Evidence
Healthcare payers, including national governments, continue to face enormous cost and capacity challenges. In order to continue delivering the best possible outcomes for patients, it is vital that new ways are found to enable therapeutics to be brought to market at a sustainable cost.